日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-G

JNJ-78306358 是一种首创的双特异性 T 细胞接合抗体,靶向 CD3 和 HLA-G。

Nataša Obermajer ,Adam Zwolak ,Kelly van de Ven ,Shana Versmissen ,Krista Menard ,Katharine Rogers ,Ted Petley ,Dan Weinstock ,Jason Aligo ,Jaymala Patel ,Ken Tian ,Lorraine Angelillo ,Fang Yi ,Stephen Jarantow ,Keith Schutsky ,Yoshitomo Hamuro ,Diana Alvarez Arias ,Kristel Buyens ,Tsun-Wen Sheena Yao ,Vince Torti ,Aleksandra Brajic ,Brian Geist ,Marjolein van Heerden ,Gerald Chu ,Bie Verbist ,Maté Ongenaert ,Julien Häsler ,Kathryn Packman ,Jacintha Shenton ,Laurie Lenox ,Jacalyn Clawson ,Regina J Brown ,Josh Lauring ,James G Greger ,Dirk Brehmer ,Sanjaya Singh ,Matthew V Lorenzi ,Sylvie Laquerre

Preclinical study of CD19 detection methods post tafasitamab treatment

tafasitamab治疗后CD19检测方法的临床前研究

Kristina Ilieva, Markus Eberl, Jan Jaehrling, Derek Blair, Maria Patra-Kneuer, Rainer Boxhammer, Diana Alvarez Arias, Christina Heitmüller

Association between prehospital medication and fatal outcomes in a cohort of hospitalized patients due to coronavirus disease-2019 in a referral hospital in Peru

秘鲁一家转诊医院收治的新冠肺炎住院患者中,院前用药与死亡结局之间的关联

Caira-Chuquineyra, Brenda; Fernandez-Guzman, Daniel; Alvarez-Arias, Priscilla Ma; Zarate-Curi, Ángel A; Herrera-Añazco, Percy; Benites-Zapata, Vicente A

Daratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)

Daratumumab 联合 Atezolizumab 治疗既往接受过治疗的晚期或转移性 NSCLC:一项随机、开放标签、1b/2 期研究的简要报告 (LUC2001 JNJ-54767414)

Pillai, Rathi N; Ramalingam, Suresh S; Thayu, Meena; Lorenzini, Patricia; Alvarez Arias, Diana A; Moy, Christopher; Hutnick, Natalie; Knoblauch, Roland; Feng, Huaibao; Kane, Colleen; Horn, Leora; Reck, Martin; Ponce, Santiago

In vivo discovery of immunotherapy targets in the tumour microenvironment

在体内发现肿瘤微环境中的免疫治疗靶点

Penghui Zhou, Donald R Shaffer, Diana A Alvarez Arias, Yukoh Nakazaki, Wouter Pos, Alexis J Torres, Viviana Cremasco, Stephanie K Dougan, Glenn S Cowley, Kutlu Elpek, Jennifer Brogdon, John Lamb, Shannon J Turley, Hidde L Ploegh, David E Root, J Christopher Love, Glenn Dranoff, Nir Hacohen, Harvey C

Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity

CD8+ Treg 活性受损会导致滤泡辅助性 T 细胞扩增和抗肿瘤免疫力增强。

Alvarez Arias, Diana A; Kim, Hye-Jung; Zhou, Penghui; Holderried, Tobias A W; Wang, Xuan; Dranoff, Glenn; Cantor, Harvey

The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells

ap-2 网格蛋白适配器介导人类 NK 细胞中抑制性杀伤细胞 Ig 样受体的内吞作用

Amanda K Purdy, Diana A Alvarez Arias, Jennifer Oshinsky, Ashley M James, Ilya Serebriiskii, Kerry S Campbell

Cryotherapy for primary treatment of prostate cancer: intermediate term results of a prospective study from a single institution

冷冻疗法作为前列腺癌的一线治疗:一项来自单一机构的前瞻性研究的中期结果

Rodríguez, S Alvarez; Arias Fúnez, F; Bueno Bravo, C; Rodríguez-Patrón Rodríguez, R; Sanz Mayayo, E; Palacios, V Hevia; Burgos Revilla, F J

Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling

Triad3A 对内化杀伤细胞免疫球蛋白样受体进行泛素化,破坏持续的 NF-κB 信号传导

S M Shahjahan Miah, Amanda K Purdy, Nicholas B Rodin, Alexander W MacFarlane 4th, Jennifer Oshinsky, Diana A Alvarez-Arias, Kerry S Campbell

Unexpected role of clathrin adaptor AP-1 in MHC-dependent positive selection of T cells

网格蛋白衔接蛋白AP-1在MHC依赖性T细胞阳性选择中的意外作用

Alvarez Arias, Diana A; McCarty, Nami; Lu, Linrong; Maldonado, Roberto A; Shinohara, Mari L; Cantor, Harvey